Drug industry

Drug industry

Who benefits: international harmonisation of the regulation of new pharmaceutical drugs

Text Size: Normal / Medium / Large
Resource Language: 
English
Owning Org: 
Centres of Excellence for Womens Health (CEWH)
Women and Health Protection (WHP)
Media Type: 
Paper
Online
Publisher: 
Women and Health Protection
Publication Date: 
2002

Explains how the push to streamline the drug approval process in the world's three largest pharmaceutical markets is neglecting the special needs of women.

ISBN/ISSN: 
WHP PHAR.W48 2002
Notes: 
Includes bibliographical references.

Influence of direct to consumer pharmaceutical advertising and patients' requests on prescribing decisions: two site cross secti

Text Size: Normal / Medium / Large
Resource Language: 
English
Owning Org: 
Centres of Excellence for Womens Health (CEWH)
Women and Health Protection (WHP)
Media Type: 
Online
Author: 
Barbara Mintzes
Morris L. Barer
Richard L. Kravitz
Arminée Kazanjian
Ken Bassett
Joel Lexchin
Robert G. Evans
Richard Pan
Stephen A. Marion
Publisher: 
British Medical Journal
Publication Date: 
2002
Publication Place: 
London, UK

Examines the relation between direct to consumer advertising and patients' requests for prescriptions and the relation between patients' requests and prescribing decisions.

Available From: 
Notes: 
Includes bibliographical references.

The marketing of fear

Text Size: Normal / Medium / Large
Resource Language: 
English
Owning Org: 
Centres of Excellence for Womens Health (CEWH)
Women and Health Protection (WHP)
Media Type: 
Online
Author: 
Ray Moynihan
Publisher: 
Australian Financial Review
Publication Date: 
2000

Examines the tactics of pharmaceutical companies, especially direct-to-consumer advertising.

Available From: 

How safe are our medicines? Monitoring the risks of drugs after they are approved for marketing

Text Size: Normal / Medium / Large
Resource Language: 
English
Owning Org: 
Centres of Excellence for Womens Health (CEWH)
Women and Health Protection (WHP)
Media Type: 
Paper
Online
Author: 
Barbara Mintzes
Women and Health Protection
Publisher: 
DES Action Canada and Women and Health Protection
Publication Date: 
2000
Publication Place: 
Montreal, QC

Discusses the drug approval process in Canada, post-approval drug surveillance, adverse drug reactions, and notification of those at risk of harm. Recommends measures to ensure drug safety for Canadian women and their families.

ISBN/ISSN: 
CEX PHAR.M56 2000
Notes: 
Includes bibliographical references.

Medical products and the Internet: WHO's guide to safe surfing

Text Size: Normal / Medium / Large
Resource Language: 
English
Media Type: 
Paper
Online
Publisher: 
Department of Essential Drugs and Medicines Policy, World Health Organization
Publication Date: 
2001
Publication Place: 
Geneva, Switaerland

Provides a guide to obtaining reliable, independent and comparable information on medical products on the World Wide Web. Developed in consultation with drug regulatory authorities, drug information experts, consumer organizations and the pharmaceutical industry.

Available From: 

Panel debates thorny issue of pharmaceutical funding

Text Size: Normal / Medium / Large
Resource Language: 
English
Owning Org: 
Canadian Women's Health Network (CWHN)
Media Type: 
Online
Author: 
Anne Rochon Ford
Publisher: 
Network/Le Réseau
Publication Date: 
1997
Publication Place: 
Winnipeg, MB

Reports on a panel discussion on the issue of women's health researchers, services, and action groups/organisations accepting funding from pharmaceutical companies.

ISBN/ISSN: 
ISSN 14800039

Power, patent and pills: an examination of GATT/WTO and essential drugs policies

Text Size: Normal / Medium / Large
Resource Language: 
English
Media Type: 
Paper
Author: 
Lisa Hayes
Publisher: 
Health Action International (HAI-Europe)
Publication Date: 
1997
Publication Place: 
Amsterdam, Netherlands

Summarizes the papers and discussions which took place during the 1996 Health Action International and BUKO Pharma-Kampagne seminar on the subject of the GATT/World Trade Organization, Pharmaceutical Policies and Essential Drugs.

ISBN/ISSN: 
ISBN 9074006078
PHAR.V36 1997

A different prescription: considerations for women's health groups contemplating funding from the pharmaceutical industry

Text Size: Normal / Medium / Large
Resource Language: 
English
Owning Org: 
Centres of Excellence for Womens Health (CEWH)
National Network on Environment and Women's Health (NNEWH)
Women and Health Protection (WHP)
Media Type: 
Online
Author: 
Anne Rochon Ford
Publisher: 
National Network on Environments and Women's Health
Publication Date: 
1999
Publication Place: 
Toronto, ON

Discusses diverse perspectives on the issue of women's health groups accepting money from the pharmaceutical industry.

Available From: 
ISBN/ISSN: 
NNEWH PHAR.F67 1999
Notes: 
Includes bibliographical references. --- Review, Network Summer 1999: A Different Prescription: Considerations for Women's Health Groups Contemplating Funding from the Pharmaceutical Industry grew out of a panel discussion called "Ethical Issues in Women's Health: The Delicate Business of Funding from Drug Companies." The booklet cuts right to the heart of the matter, going over different scenarios and giving advice on what groups should ask themselves when considering this type of funding. It also lists plenty of other reading materials on the topic.

Problem drugs pack

Text Size: Normal / Medium / Large
Resource Language: 
English
Media Type: 
Paper
Author: 
Andrew Chetley
Publisher: 
Health Action International
Publication Date: 
1994
Publication Place: 
Amsterdam, The Netherlands

Provides an information pack on various categories of problem drugs and special prescribing needs for women, children and the elderly. Highlights examples of unethical & double standards in marketing.

Blurring the boundaries: new trends in drug promotion

Text Size: Normal / Medium / Large
Resource Language: 
English
Media Type: 
Paper
Online
Author: 
Barabara Mintzes
Publisher: 
Health Action International
Publication Date: 
1998
Publication Place: 
Amsterdam, The Nethelands

Explores the impact of blurred boundaries between drug promotion and objective information on consumer health, access to appropriate health services, and the information on which treatment decisions are based.

ISBN/ISSN: 
PHAR.M56 1998
Notes: 
<p>Includes bibliographical references. --- Review, Network Fall 1998: Blurring the Boundaries: New Trends in Drug Promotion takes a critical look at the new "partnerships" between the pharmaceutical industry and health and social services. It examines new trends in the way medicines are marketed and points out the imbalance between the amount of money shovelled into pharmaceutical advertising and the amount put into independent research on the drugs advertised. Just in time for our own Health Protection Branch's "transition", Barbara Mintzes' study for Health Action International gives several recommendations on regulating and monitoring drug promotion. "At stake here," says Mintzes, "is whether consumer health or commercial interests are to be given priority."</p>
Syndicate content